Study of the Risk Factors and Outcomes After Gastrointestinal Bleeding
NCT02514304 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 4745
Last updated 2025-07-31
Summary
The purpose of this multicenter, two component observational and standardized case-control study is to evaluate risk factors of gastrointestinal (GI) bleeding with a prospective 3-month and 12-month follow-up to examine outcomes and their possible causes.
Conditions
- Gastrointestinal Hemorrhage
- Cardiovascular Diseases
Sponsors & Collaborators
-
Heart and Stroke Foundation of Ontario
collaborator OTHER - collaborator INDUSTRY
- collaborator INDUSTRY
-
Population Health Research Institute
lead OTHER
Principal Investigators
-
John Eikelboom, MD · Population Health Research Institute, McMaster University
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-09-30
- Primary Completion
- 2023-12-15
- Completion
- 2024-12-31
Countries
- Canada
Study Locations
More Related Trials
-
Gastrointestinal Endoscopy in Patients With Prothrombotic Conditions: THE ENDOHEM REGISTRY
NCT03669068 ·Status: COMPLETED
-
High Gastrointestinal Bleed Risk Outcomes in Patients With Non-valvular Atrial Fibrillation (NVAF) in France
NCT05038228 ·Status: ACTIVE_NOT_RECRUITING
-
Effect of Inhibitors of the Proton Pump on Intestinal Transporters
NCT02524210 ·Status: COMPLETED ·Phase: PHASE1
-
Predicting Bleeding Risk on Anticoagulant Therapy for Venous Thromboembolism
NCT00788736 ·Status: COMPLETED
-
Early Versus Late Resumption of Anticoagulation in Patients With Both High Thrombosis Risk and Major HEmoRrhage
NCT02091479 ·Status: TERMINATED ·Phase: PHASE3
-
Patient-Centered Anticoagulation Self-Monitoring in Minority Patients
NCT02776566 ·Status: COMPLETED ·Phase: NA
-
Anticoagulation With Enhanced Gastrointestinal Safety
NCT05563714 ·Status: COMPLETED ·Phase: NA
-
Real-World Comparative Observational Study in Non-Valvular Atrial Fibrillation Patients Using Oral Anticoagulants
NCT02754154 ·Status: COMPLETED
-
Comparison of the Effect of Warfarin and Direct Oral Anticoagulants
NCT06269302 ·Status: COMPLETED
-
A Nationwide Registry Study of Patients With Nonvalvular Atrial Fibrillation Initiating Oral Anticoagulation Therapies In The Early Period Following Apixaban Marketing In Denmark
NCT02591732 ·Status: COMPLETED
-
Clinical and Economic Burden of Bleeding Events in Patients in the UK With Non-valvular Atrial Fibrillation Treated With Vitamin k Antagonists
NCT02661516 ·Status: COMPLETED
-
Observatory of Invasive Procedures and Bleeding in Patients Treated With New Oral Anticoagulants
NCT02185027 ·Status: COMPLETED
-
Understanding Risk Factors Involved in Developing a Second Blood Clot.
NCT00261014 ·Status: UNKNOWN
-
Compare VKA vs LMWH in Patients With Anticoagulation Criteria and Episode of Gastrointestinal Bleeding.
NCT01727453 ·Status: COMPLETED ·Phase: PHASE4
-
A Clinical Cohort Study of Safety and Effectiveness of Venous Thromboembolism Prophylaxis in Critical Ill Patients
NCT02213978 ·Status: COMPLETED
-
An Observational Study to Evaluate the Incidence of MACCE According to Time Interval of Taking Medication in Patients With Acute Coronary Syndrome or Cerebral Infarction Who Received DAPT for the Secondary Prevention and Esomezol Cap for the Prevention of Gastrointestinal Bleeding
NCT05487560 ·Status: COMPLETED
-
The Role of Platelet Surface α2β1 Integrin Expression as a Risk Factor in Thrombotic and/or Bleeding Complications
NCT00603148 ·Status: COMPLETED
-
A Multifaceted Intervention to Improve Bleeding Management Among Patients Using Oral Anticoagulants (IMPACT-BLEEDING)
NCT06575517 ·Status: WITHDRAWN
-
Clinical Predictors for Venous Thromboembolism in Patients With a History of Thrombosis (PREDICTORS)
NCT02297373 ·Status: COMPLETED
-
Six Years of Follow-up After Idiopathic Venous Throbmoembolism
NCT02884934 ·Status: COMPLETED
-
Safety of Oral Anticoagulants Registry
NCT02745054 ·Status: UNKNOWN
-
Venous Thromboembolism in Hematologic Malignancy and Hematopoietic Cell Transplant Patients: a Retrospective Study
NCT05396157 ·Status: ACTIVE_NOT_RECRUITING
-
Prospective Evaluation of Bleeding Risk of Anticoagulant and Anti-platelet Therapy
NCT00625248 ·Status: COMPLETED
-
Prolongation of the Interval Between Prothrombin Time Tests in Stable Patients II
NCT01654042 ·Status: WITHDRAWN ·Phase: PHASE3
-
Strategy of Continued Versus Interrupted Novel Oral Anti-coagulant at Time of Device Surgery in Patients With Moderate to High Risk of Arterial Thromboembolic Events
NCT01675076 ·Status: COMPLETED ·Phase: PHASE3